• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns

Prognosis: No Competition Yet Between HPV Types

November 19, 2011 By Jonathan Leave a Comment

New York Times Vital Signs By NICHOLAS BAKALAR Published: November 14, 2011 The two vaccines against human papillomavirus together target the four types of HPV that cause a large majority of cervical and anal cancers. But there are more than a dozen other cancer-causing HPV types, and scientists have been concerned that as more people […]

Filed Under: Anal Cancer, Cervical Cancer, HPV, United States, Women's Health Tagged With: Anal Cancer, Anne F. Rositch, Cervical Cancer HPV, HPV

Targeting HPV 16/18 shows promise in cancer risk reduction

September 1, 2011 By Jonathan Leave a Comment

Infectious Disease News Posted August 26, 2011 New vaccine provides ‘strong protection’ for anal cancer, and researchers discover that separate screening for HPV 16/18 may represent a more effective screening strategy. Results from two recently released studies show that researchers are seeing progress in preventing HPV-related anal cancer and in screening for HPV-related cervical cancer. […]

Filed Under: Anal Cancer, Cervarix, Clinical Trials, GlaxoSmithKline Tagged With: Anal Cancer, cervarix, GlaxoSmithKline, HPV vaccine trials, Vaccine Adverse Reactions

SaneVax Pregunta a la FDA sobre Gardasil ® ¿Que están haciendo?

April 16, 2011 By Jonathan Leave a Comment

BWN Argentina – Ultimas Noticias Argentina April 15, 2010 Médicos de todo el mundo y el publico aplauden la reciente decisión de la FDA de no ampliar el uso de Gardasil para mujeres mayores de 26 años de edad. Ahora quieren saber cuándo la FDA admitirá que la aprobación original para niñas fue un error. […]

Filed Under: Anal Cancer, Cervical Cancer, Gardasil / Silgard Injuries, Merck & Co., SANE Vax in the News Tagged With: Cervical Cancer HPV, Gardasil, HPV vaccinations, Sane Vax, Vaccine Adverse Reactions

November 16-17, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Summary Minutes

April 5, 2011 By Jonathan Leave a Comment

Food and Drug Administration Center for Biologics Evaluation and Review SUMMARY MINUTES VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE November 16 – 17, 2010 Silver Spring Hilton, Silver Spring, MD The Chair, Dr. Jack Stapleton, called the Meeting of the Vaccines and Related Biological Products Advisory Committee to order at 9:00 a.m. EST on November […]

Filed Under: Anal Cancer, Anthrax, Gardasil / Silgard, Vaccine Adverse Events Tagged With: Anal Cancer, anthrax vaccine, Cervical Cancer HPV, vaccinations, Vaccine Adverse Reactions

HPV Affects Half Of U.S. Men

March 2, 2011 By Jonathan Leave a Comment

The Huffington Post Dr. Jon LaPook Medical correspondent for the CBS Evening News with Katie Couric Posted: March 1, 2011 07:02 AM A study out yesterday in The Lancet by Moffitt Cancer Center researcher Anna Giuliano, Ph.D., and her colleagues finds that 50 percent of men ages 18 to 70 in Brazil, Mexico, and the […]

Filed Under: Anal Cancer, Cervarix, Gardasil / Silgard, Oral Cancer, Pharmaceuticals, STD's, Vaccine Marketing, Vaccine Politics/People Tagged With: Autoimmune Diseases, cervarix, Cervical Cancer HPV, GlaxoSmithKline, HPV, Merck, STD's, vaccinations, Vaccine Adverse Reactions

  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Zeda from Indiana

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Subscribe2


 

Log In

Featured Video

France discusses the aluminum adjuvants safety

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...